Teleflex Incorporated $TFX Shares Purchased by Next Capital Management LLC

Next Capital Management LLC increased its holdings in shares of Teleflex Incorporated (NYSE:TFX) by 32.3% during the 2nd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm owned 10,423 shares of the medical technology company’s stock after acquiring an additional 2,543 shares during the quarter. Next Capital Management LLC’s holdings in Teleflex were worth $1,234,000 at the end of the most recent quarter.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. Thurston Springer Miller Herd & Titak Inc. grew its position in Teleflex by 242.9% in the 2nd quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company’s stock worth $26,000 after purchasing an additional 153 shares during the last quarter. Banque Cantonale Vaudoise bought a new position in Teleflex in the 1st quarter worth about $27,000. Costello Asset Management INC bought a new position in Teleflex in the 1st quarter worth about $28,000. Brooklyn Investment Group grew its position in Teleflex by 258.6% in the 1st quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company’s stock worth $29,000 after purchasing an additional 150 shares during the last quarter. Finally, Allworth Financial LP grew its position in Teleflex by 504.8% in the 1st quarter. Allworth Financial LP now owns 254 shares of the medical technology company’s stock worth $34,000 after purchasing an additional 212 shares during the last quarter. Institutional investors and hedge funds own 95.62% of the company’s stock.

Insider Activity at Teleflex

In other news, Director Gretchen R. Haggerty purchased 500 shares of Teleflex stock in a transaction that occurred on Wednesday, August 6th. The stock was acquired at an average price of $114.75 per share, for a total transaction of $57,375.00. Following the transaction, the director owned 6,305 shares in the company, valued at $723,498.75. The trade was a 8.61% increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is available at this link. Company insiders own 1.40% of the company’s stock.

Teleflex Stock Down 1.5%

Shares of NYSE:TFX opened at $122.66 on Tuesday. The company has a debt-to-equity ratio of 0.42, a quick ratio of 1.44 and a current ratio of 2.41. The company has a market cap of $5.42 billion, a PE ratio of 28.86, a price-to-earnings-growth ratio of 1.79 and a beta of 1.05. Teleflex Incorporated has a 52 week low of $108.90 and a 52 week high of $212.16. The firm has a 50 day simple moving average of $126.51 and a 200 day simple moving average of $123.39.

Wall Street Analysts Forecast Growth

Several research firms have commented on TFX. Mizuho upped their target price on shares of Teleflex from $130.00 to $135.00 and gave the stock a “neutral” rating in a research report on Friday, August 1st. Wall Street Zen cut shares of Teleflex from a “strong-buy” rating to a “buy” rating in a report on Monday, September 15th. Wells Fargo & Company decreased their price objective on shares of Teleflex from $137.00 to $131.00 and set an “equal weight” rating for the company in a report on Friday, August 1st. Zacks Research cut shares of Teleflex from a “strong-buy” rating to a “hold” rating in a report on Tuesday, September 30th. Finally, Royal Bank Of Canada increased their target price on shares of Teleflex from $130.00 to $135.00 and gave the company a “sector perform” rating in a research note on Friday, August 1st. One research analyst has rated the stock with a Buy rating, nine have given a Hold rating and two have given a Sell rating to the company. Based on data from MarketBeat, Teleflex has an average rating of “Reduce” and a consensus target price of $141.57.

Teleflex Profile

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.